Cargando…
CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?
Autor principal: | Gahrton, Gösta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542833/ https://www.ncbi.nlm.nih.gov/pubmed/36891744 http://dx.doi.org/10.3324/haematol.2023.282896 |
Ejemplares similares
-
Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?
por: Gahrton, Gösta, et al.
Publicado: (2020) -
The Road to a Cure: Emerging Treatments for Multiple Myeloma
por: Caers, Jo
Publicado: (2020) -
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
por: Nahi, Hareth, et al.
Publicado: (2019) -
Driving CARs to new places: locally produced BCMA CAR T cells to treat multiple myeloma
por: Sjöstrand, Maria, et al.
Publicado: (2023) -
CAR-T Cell Therapy for HIV Cure
por: Salgado, Maria
Publicado: (2023)